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Background: While performing sacrectomy from a posterior approach enables the en bloc resection of sacral
tumors, it can result in deep posterior peritoneal defects and postoperative complications. We investigated whether
defect reconstruction with gluteus maximus (GLM) adipomuscular sliding flaps would improve patient outcomes.
Methods: Between February 2007 and February 2012, 48 sacrectomies were performed at He Nan Cancer Hospital,
Zhengzhou City, China. We retrospectively examined the medical records of each patient to obtain the following
information: demographic characteristics, tumor location and pathology, oncological resection, postoperative
drainage and complications. Based on the date of the operation, patients were assigned to two groups on the
basis of closure type: simple midline closure (group 1) or GLM adipomuscular sliding reconstruction (group 2).
Results: We assessed 21 patients in group 1 and 27 in group 2. They did not differ with regards to gender, age,
tumor location, pathology or size, or fixation methods. The mean time to last drainage was significantly longer in
group 1 compared to group 2 (28.41 days (range 17–43 days) vs. 16.82 days (range 13–21 days, P < 0.05)) and the
mean amount of fluid drained was higher (2,370 mL (range 2,000–4,000 mL) vs. 1,733 mL (range 1,500–2,800 mL)).
The overall wound infection rate (eight (38.10%) vs. four (14.81%), P < 0.05) and dehiscence rate (four (19.05%)] vs.
three (11.11%), P < 0.05) were significantly higher in group 1 than in group 2. The rate of wound margin necrosis
was lower in group 1 than in group 2 (two (9.82%) vs. three (11.11%), P < 0.05).
Conclusions: The use of GLM adipomuscular sliding flaps for reconstruction after posterior sacrectomy can
significantly reduce the risk of infection and improve outcomes.
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Sacral tumors include benign subtypes, such as giant-
cell tumors [1] and aneurysmal bone cysts [2], as well as
malignant subtypes, including chordomas, multiple mye-
lomas and metastatic tumors [3]. These tumors are often
asymptomatic or involve vague signs and symptoms [4],
such as backache with or without numbness, leg weakness
or bowel and/or bladder dysfunction. Therefore, diagnosis
is frequently delayed by several months to up to 6 years
[5]. During the interim, the tumors can become very large
and may destroy most segments of the sacrum.* Correspondence: ywtwhm@163.com
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reproduction in any medium, provided the orTreatment ranges from intralesional curettage [6] to
ablation to en bloc excision [7]. Surgical resection can
result in large defects that extend to the rectum ventrally
or to the sacroiliac joints laterally. Defects can disrupt
the posterior pelvic wall and often present a reconstruct-
ive challenge to surgeons [8]. The musculature over the
sacrum can become weakened or of insufficient volume
to fill large defects. Simple midline closures usually fail,
which can lead to infection [9], wound breakdown,
parasacral herniation or a combination of these compli-
cations, which may delay adjuvant treatment [10].
Good results have been reported with the use of verti-
cal rectus abdominis myocutaneous flaps [11]. Other
methods have involved meshes [12], omental mobilization
[13] and free flaps [14]; however, some of these methodsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and/or dangerous complications, such as necrosis [15].
We performed a retrospective study to assess whether re-
construction with gluteus maximus (GLM) adipomuscular
sliding flaps would improve outcomes after sacral tumor
excision.
Methods
We assessed patients who had undergone sacrectomy
because of sacral tumors between February 2007 and
February 2012. All patients, or guardians when appropri-
ate, gave informed consent before surgery. The authors
obtained approval from the ethics committee of our hos-
pital before doing the study.
During sacrectomy, complete spondylectomies to the
appropriate levels and sectioning of the bilateral piriform
muscles and of the bilateral sacrospinous and sacro-
tuberous ligaments were carried out. The sacral nerveFigure 1 Reconstruction of the sacral defect caused by tumor resectio
flaps. A huge defect is left after sacral tumor resection (a). Separation of th
of the GLM adipomuscular flap (c). The defect is eliminated by advancemeroots (above sacral vertebra S3) of involved segments on
both sides were separated and protected (Figure 1a). If
total sacrectomy was performed, complex lumbopelvic re-
construction and arthrodesis were undertaken with au-
tologous iliac crest bone grafts and instrumentation (for
example, bilateral lumbar vertebrae L4 and L5 pedicle
screws and iliac screws). Blood loss was controlled by tem-
porary abdominal aorta block during sacrectomy of S1.
Based on the date of the operation, from February
2007 to December 2010, patients who underwent simple
midline closure by two-layer suture of the fascia and
skin comprised group 1. From January 2011 to January
2013, patients were chosen for GLM adipomuscular slid-
ing flaps reconstruction if they had undergone resection
of a sacral tumor via an exclusively posterior approach,
had no tumor invasion on either side of the GLM
muscle on MRI before surgery (Figure 2a), had adequate
blood supply to the GLM flap and had not undergonen with bilateral gluteus maximus (GLM) adipomuscular sliding
e GLM adipomuscular flap on one side (b). Separation of another side
nt of the bilateral GLM adipomuscular flaps (d).
Figure 2 Magnetic resonance imaging of the tumor and flap. Sacral tumor and intact gluteus maximus (GLM) (arrow) before surgery (a).
Well-maintained GLM adipomuscular flap (arrow) behind the rectum (b) 6 months after surgery.
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group 2.
One or both sides of the GLM adipomuscular sliding
flaps were used to fill the dead space at the posterior
peritoneum defect depending on the invasion and resec-
tion of GLM (see Figure 2a). In cases where both sides
of the GLM were intact with no resection during the op-
eration, bilateral flaps were used to fill the defect. When
the GLM was invaded by tumors and wide resection was
undertaken, the other side of the muscle flap was used
to slide into the defect.
The first step was elevating the gluteal skin flap, in-
cluding the superficial fascia, based on the lumbar
vascular perforation. The deep adipose tissue beneath
the superficial fascia was left on the GLM muscle (see
Figure 1b and c). The separation area included the fol-
lowing: the upper boundary of the flap reaching the iliac
crest, the low boundary of the buttock line according to
the area of the posterior peritoneal defect, and the 6 to
10 cm of adipomuscle that lay in between. Then, the
unilateral or bilateral adipomuscular flaps were slid into
the retroperitoneal space and sutured together in the
midline to obliterate the dead space (see Figure 1d).
Wound drainages were placed into the bone defect and
the subcutaneous cave of all patients after surgery.
All patients ate a normal diet after surgery. Early am-
bulation was allowed in patients whose procedures did
not involve instrumentation. By 2 weeks post-surgery,
patients without instrumentation were allowed to get
out of bed supervised by a physiotherapist. If patients
had undergone lumbopelvic reconstruction and arthrod-
esis, weight-bearing activity was delayed until new bone
formation was seen at the sites of bone grafting. Gait
was evaluated with the following grades: normal, slight
limp and severe limp. Movement of hip joints was mea-
sured and recorded.
Wound drainage was continued in all patients for at
least 2 weeks. Drains were removed when the outputwas 5 mL or less for two consecutive days. The number
of days to final drainage and the amount of fluid drained
were both recorded. Chemotherapy or radiotherapy were
used to treat multiple myelomas or metastatic tumors
after wound healing.
Postoperatively, all patients were discharged from the
hospital when the wound healed and the drains were re-
moved. They were followed up on a monthly basis for 3
months, and were then seen every 3 months for 2 years,
and every 6 months for years 3 to 4. At each visit, pa-
tients underwent radiography of the sacral area and
physical examination. Magnetic resonance imaging
(MRI) was used to assess local tumor collapse 12 to 48
months post-operation in selected patients who had
giant-cell tumors, chordomas, multiple myelomas and
metastatic tumors.
We recorded the sex, age, sacral segment, pathology,
size of tumor and resection and fixation methods in a
coded spreadsheet. Statistical analysis was conducted
with the SPSS statistical software package (version 11.5;
Chicago, IL, USA). Sex, age, sacral segment, pathology,
size of the defect, the type of resection methods and re-
construction, postoperative complications (infection, flap
necrosis, wound dehiscence and parasacral hernia) and
functional outcomes (such as gait) were compared be-
tween groups 1 and 2 with a nonparametric independent-
samples t-test. The movement of hip joints, mean time to
last drainage and the mean total amount of fluid drained
were compared with an independent-samples t-test. A dif-
ference with P <0.05 was considered to be statistically
significant.
Results
The patient population consisted of 32 men and 16
women, with a mean age of 56.82 years and a range of
23 to 83 years. The histological diagnoses and sacral seg-
ments removed are shown in Table 1. Group 1 com-
prised 21 patients and group 2 comprised 27 patients.
Table 1 Characteristics of patients grouped by closure
method
Group 1 Group 2 P-value
Gender
Male 13 (61.90%) 19 (70.37%) 0.85
Female 8 (38.10%) 8 (29.63%)
Age, years
20 to 40 3 (14.29%) 5 (18.52%) 0.06
40 to 60 11 (52.38%) 16 (59.26%)
60 to 80 7 (33.33%) 6 (22.22%)
Segment of sacrum
S4 to S5 1 (4.76%) 1 (3.70%) 0.06
S4 to S3 2 (9.82%) 4 (14.81%)
S2 to S3 6 (28.57%) 7 (25.93%)
S1 to S2 7 (33.33%) 10 (37.04%)
L5 to S1 5 (23.81%) 5 (18.52%)
Pathology
Chordomas 12 (57.14%) 14 (51.85%) 0.05
Multiple myelomas 2 (9.52%) 3 (11.11%)
Metastatic tumors 2 (9.52%) 5 (18.52%)
Giant-cell tumor 4 (19.05%) 3 (11.11%)
Others 1 (4.67%) 1 (3.70%)
Size of tumor, diameter
<10 cm 11 (52.38%) 6 (22.22%) 0.11
10 to 20 cm 7 (33.33%) 14 (51.85%)
>20 cm 3 (14.29%) 7 (25.93%)
Resection methods
Radical resection 10 (47.62%) 14 (51.85%) 0.02
Marginal resection 6 (28.57%) 9 (33.33%)
Intradural curettage 5 (23.81%) 4 (14.81%)
Fixation
Yes 10 (47.62%) 14 (51.85%) 0.84
No 11 (52.38%) 13 (48.15%)
Data are number (%).
Table 2 Surgical outcomes according to treatment group
Drainage and complications Group 1 Group 2 P-value
Time to last drainage, days 28.41 ± 11.05 16.82 ± 7.38 0.02
Amount of fluid drained, mL 2370 ± 284 1733 ± 326 0.00
Wound infection 8 (38.10%) 4 (14.81%) 0.00
Wound margin necrosis 2 (9.82%) 3 (11.11%) 0.00
Wound dehiscence 4 (19.05%) 3 (11.11%) 0.00
Data are mean ± SD or number (%).
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demographic or pathological characteristics, size of
tumor or fixation (Table 1). The mean diameter of sacral
defects was 17.4 cm (range 6.5 to 35.8 cm). In group 2,
bilateral GLM adipomuscular sliding flaps were used in
23 patients, while unilateral GLM adipomuscular sliding
flaps were used in 4 patients. The flaps enabled the
successful reconstruction of the posterior peritoneal de-
fect, and the volume of the flap was well maintained
behind the rectum on postoperative MRI in all cases
(Figure 2b).
Four patients died as a result of the primary disease
within 9 to 24 months, and seven patients had a relapse
at the site of the operation during the 10 to 32 monthfollow up period in the two groups. The mean time to
final drainage and the mean amount of fluid drained dif-
fered significantly between the two groups, with better
outcomes seen in group 2 (Table 2). Eight patients in
group 1 and four patients in group 2 developed wound
infections 2 to 4 weeks after surgery, and this difference
was statistically significant (Table 2). The rate of wound
dehiscence was lower in group 2 than in group 1 (three
(11.11%) versus four (19.05%), P <0.05). However, mar-
gin necrosis was more frequent in group 2 than in group
1 (three (11.11%) versus two (9.82%), P <0.05). Gait and
hip joint movement were preserved in all cases, irre-
spective of closure method.
Discussion
As sacral tumors are often asymptomatic or the symp-
toms are vague (low-back pain with or without numb-
ness, leg weakness or bowel and/or bladder dysfunction),
diagnosis is frequently delayed by several months to sev-
eral years, depending on the rate of tumor growth [5].
Thus, at the time of diagnosis, the sacral roots might be
involved or even have been destroyed. Tumors can be-
come very large and extend into the surrounding soft
tissue, including the GLM muscles, the presacral space
and beyond the sacroiliac joints to the ileum.
The first-line treatment for sacral tumors is surgery,
and is often radical, or may involve marginal surgical ex-
cision. Extensive resection, however, always leaves a large
defect, usually with a diameter of 6.5 to 35.8 cm that ex-
tends laterally from the sagittal lumbar spine to the
sacroiliac joints. In these cases, simple midline closures
generally fail and have a high risk of wound infection or
dehiscence. Development of successful techniques for
reconstruction of these defects is, therefore, important
to lower the risk of complications.
Many techniques have been used for reconstruction
after sacrectomy, including myocutaneous flaps, free
flaps and mesh. The most commonly used is trans-pelvic
vertical rectus abdominis myocutaneous flaps, which in-
volves a circumferential approach. This method has sev-
eral advantages, including the ease of the procedure,
providing suitable bulk, a long pedicle, adequate blood
supply and re-creation of the pelvic floor [16]. Use of
this method in conjunction with a laparotomy or
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dominal wall and causes incisional hernia [17]. The use
of free flaps has been described for lumbosacral recon-
struction when local flaps are destroyed. The first-choice
recipient vessels are the superior or inferior gluteal ves-
sels because they lay in or beside the defect [18]. If these
vessels are unavailable, the femoral and thoracodorsal
vessels may be used; however, this approach requires
long vein grafts and potentially increases the risk of
skin-flap necrosis [19]. Koh PK et al. [20] have reported
the use of the GLM muscle turnover flaps for recon-
struction of sacral chordoma defects. The advantages of
using the GLM muscle are its bulk, proximity to the de-
fect and robust blood supply. The disadvantages of this
approach include the necessity of an additional incision,
destruction of some of the GLM blood supply and the
risk of gluteal gait.
The blood supply of the GLM muscle consists of the
superior and inferior gluteal arteries, which communi-
cate with perforating branches from the femoral system
and the medial femoral circumflex arteries to form an
intricate cruciate anastomosis around the hip. Because
of this rich blood supply, the use of GLM flaps is feasible
for defect reconstruction in selected patients. With the
adipomuscular sliding flaps technique, the muscles are
not elevated but are simply advanced toward the mid-
line, which leaves their insertions untouched. The sutur-
ing of each muscle to its contralateral counterpart
creates a strong posterior peritoneal repair that employs
the blood supply of both the superior and inferior pedi-
cles. During the operation, none of the blood vessels
need to be exposed or elevated, which makes this flap
operation safe and easy. This method, however, yields
less flap volume and less moving distance than the other
GLM flap approaches reported previously [20], and is
only suitable for defects less than 30 cm in diameter.
This type of flap surgery was performed in all group 2
patients in this study because of its convenience and be-
cause most sacral tumors have less invasion to the GLM
muscle.
The use of GLM adipomuscular sliding flaps has many
advantages over other reconstruction and closure ap-
proaches. As well as the robust blood supply mentioned
above, the GLM muscle is large and the anatomic loca-
tion is proximal to the sacrum. Moreover, no additional
intraoperative incisions or repositioning of the patient
are required. When a sacrectomy is performed from a
posterior approach, the three main blood supply routes
are not routinely sacrificed. The retention of a native
and robust blood supply may be central to the long-term
durability and viability of flaps. The separation and
movement of flaps is much easier than other kinds of
GLM flap approaches, such as the use of antegrade or
retrograde GLM rotation flaps described by Koh et al.and Vogt et al. [19,20]. The bulk achieved with GLM
adipomuscular sliding flaps helps protect the blood sup-
ply and makes these approaches ideal for sacral defects.
Our results show that in group 2, both the time to
final drainage and the amount of fluid drained were sig-
nificantly reduced compared to group 1. The rates of in-
fection and wound dehiscence were also significantly
lower in group 2 relative to group 1. GLM adipomuscular
sliding flaps appear, therefore, to form a protective layer
while also absorbing cavity effusion, which may be the rea-
sons underlying the reduced rate of perianal infection. Be-
cause of the poor blood circulation in subcutaneous tissue
of the gluteal groove, however, flap necrosis cannot be
improved.
Since the GLM muscle is the primary extensor of the
hip, the potential drawbacks of using GLM flaps are
functional disturbance in ambulation, especially when
walking upstairs or straightening from a bending pos-
ition, and pelvic instability [21]. We found no difference
between the two groups with regards to ambulatory sta-
tus. This finding might have arisen because the bilateral
advancement flap technique was used in most patients,
which does not hinder active extension of the hip and is
compensated by gradual hypertrophy of the hamstring
muscle and the adductor magnus. Other potential ad-
verse side effects that come with use of GLM adipo-
muscular sliding flaps include poor extensibility, which
can lead to excessive traction on the flap. Additionally,
the flaps may not have enough bulk to cover the defect,
especially if most of the GLM muscle on one side needs
to be removed.
Conclusions
Our experience suggests that reconstruction with GLM
adipomuscular sliding flaps improves outcomes after
sacrectomy. The use of unilateral or bilateral GLM
adipomuscular sliding flaps should therefore be consid-
ered in patients who have not undergone prior radiation
therapy, who have intact GLM muscles with gluteal ves-
sels on one or both sides and who have defects less than
30 cm in diameter. This technique had low rates of com-
plications and morbidity, was easy to perform, and had
high success rates.
Competing interest
The authors declare that they have no competing interests.
Authors’ contribution
All authors read and approved the final manuscript.
Received: 20 February 2013 Accepted: 16 May 2013
Published: 23 May 2013
References
1. Balke M, Henrichs MP, Gosheger G, Ahrens H, Streitbuerger A, Koehler M,
Bullmann V, Hardes J: Giant cell tumors of the axial skeleton. Sarcoma 2012,
2012:410973.
Weitao et al. World Journal of Surgical Oncology 2013, 11:110 Page 6 of 6
http://www.wjso.com/content/11/1/1102. Donati D, Frisoni T, Dozza B, DeGroot H, Albisinni U, Giannini S: Advance in
the treatment of aneurysmal bone cyst of the sacrum. Skeletal Radiol
2011, 40:1461–1466.
3. Syed R, Bishop JA, Ali SZ: Sacral and presacral lesions: cytopathologic
analysis and clinical correlates. Diagn Cytopathol 2012, 40:7–13.
4. Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, Zeuli M,
Giannarelli D, Cognetti F, Biagini R: Chordoma: clinical characteristics,
management and prognosis of a case series of 25 patients. BMC Cancer
2010, 10:22.
5. Lee J, Bhatia NN, Hoang BH, Ziogas A, Zell JA: Analysis of prognostic
factors for patients with chordoma with use of the California Cancer
Registry. J Bone Joint Surg Am 2012, 94:356–363.
6. Quraishi NA, Giannoulis KE, Edwards KL, Boszczyk BM: Management of
metastatic sacral tumours. Eur Spine J 2012, 21:1984–1993.
7. Clarke MJ, Dasenbrock H, Bydon A, Sciubba DM, McGirt MJ, Hsieh PC, Yassari R,
Gokaslan ZL, Wolinsky JP: Posterior-only approach for en bloc sacrectomy:
clinical outcomes in 36 consecutive patients. Neurosurgery 2012, 71:357–364.
8. Garvey PB, Rhines LD, Feng L, Gu X, Butler CE: Reconstructive strategies for
partial sacrectomy defects based on surgical outcomes. Plast Reconstr
Surg 2011, 127:190–199.
9. Ruggieri P, Angelini A, Pala E, Mercuri M: Infections in surgery of primary
tumors of the sacrum. Spine (Phila Pa 1976) 2012, 3:420–428. 1.
10. Asavamongkolkul A, Waikakul S: Wide resection of sacral chordoma via a
posterior approach. Int Orthop 2012, 36:607–612.
11. Horch RE, D'Hoore A, Holm T, Kneser U, Hohenberger W, Arkudas A:
Laparoscopic abdominoperineal resection with open posterior cylindrical
excision and primary transpelvic VRAM flap. Ann Surg Oncol 2012, 19:502–503.
12. Dasenbrock HH, Clarke MJ, Bydon A, Witham TF, Sciubba DM, Simmons OP,
Gokaslan ZL, Wolinsky JP: Reconstruction of extensive defects from
posterior en bloc resection of sacral tumors with human acellular dermal
matrix and gluteus maximus myocutaneous flaps. Neurosurgery 2011,
69:1240–1247.
13. Unal C, Eren GG, Isil E, Alponat A, Sarlak A: Utility of the omentum in sacral
reconstruction following total sacrectomy due to recurrent and irradiated
giant cell tumour of the spine. Indian J Plast Surg 2012, 45:140–143.
14. Stechl NM, Baumeister S, Grimm K, Kraus TW, Bockhorn H, Exner KE:
Microsurgical reconstruction of the pelvic floor after pelvic exenteration.
Reduced morbidity and improved quality of life by an interdisciplinary
concept. Chirurg 2011, 82:625–630.
15. Diaz J, McDonald WS, Armstrong M, Eismont F, Hellinger M, Thaller S:
Reconstruction after extirpation of sacral malignancies. Ann Plast Surg
2003, 51:126–129.
16. Glatt BS, Disa JJ, Mehrara BJ, Pusic AL, Boland P, Cordeiro PG:
Reconstruction of extensive partial or total sacrectomy defects with a
transabdominal vertical rectus abdominis myocutaneous flap. Ann Plast
Surg 2006, 56:526–531.
17. Daigeler A, Simidjiiska-Belyaeva M, Drücke D, Goertz O, Hirsch T, Soimaru C,
Lehnhardt M, Steinau HU: The versatility of the pedicled vertical rectus
abdominis myocutaneous flap in oncologic patients. Langenbecks Arch
Surg 2011, 396:1271–1279.
18. Park S: Muscle-splitting approach to superior and inferior gluteal vessels:
versatile source of recipient vessels for free-tissue transfer to sacral,
gluteal, and ischial regions. Plast Reconstr Surg 2000, 106:81–86.
19. Vogt PM, Kall S, Lahoda LU, Spies M, Muehlberger T: The free "mutton
chop" flap: a fascio-musculocutaneous flap for the reconstruction of the
entire sacral and perineal area. Plast Reconstr Surg 2004, 114:1220–1224.
20. Koh PK, Tan BK, Hong SW, Tan MH, Tay AG, Song C, Tan KC: The gluteus
maximus muscle flap for reconstruction of sacral chordoma defects.
Ann Plast Surg 2004, 53:44–49.
21. Haapamäki MM, Pihlgren V, Lundberg O, Sandzén B, Rutegård J: Physical
performance and quality of life after extended abdominoperineal
excision of rectum and reconstruction of the pelvic floor with gluteus
maximus flap. Dis Colon Rectum 2011, 54:101–106.
doi:10.1186/1477-7819-11-110
Cite this article as: Weitao et al.: Use of gluteus maximus adipomuscular
sliding flaps in the reconstruction of sacral defects after tumor
resection. World Journal of Surgical Oncology 2013 11:110.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
